Amyloid-β: a chameleon walking in two worlds: a review of the trophic and toxic properties of amyloid-β
about
Targeting the proper amyloid-beta neuronal toxins: a path forward for Alzheimer's disease immunotherapeuticsA Review on Potential Mechanisms of Terminalia chebula in Alzheimer's DiseaseThe airbag problem-a potential culprit for bench-to-bedside translational efforts: relevance for Alzheimer's diseaseIron chelation and multiple sclerosisAmyloid beta: multiple mechanisms of toxicity and only some protective effects?Resveratrol acts not through anti-aggregative pathways but mainly via its scavenging properties against Aβ and Aβ-metal complexes toxicityRole of the MEOX2 homeobox gene in neurovascular dysfunction in Alzheimer diseaseThe beta-amyloid precursor protein controls a store-operated Ca2+ entry in cortical neurons.In vivo evaluation of microglia activation by intracranial iron overload in central pain after spinal cord injuryIron and mechanisms of neurotoxicityThe pathogenesis of Alzheimer's disease: a reevaluation of the "amyloid cascade hypothesis"An update on using vitamin E in Alzheimer's disease.Metal-protein attenuating compounds and Alzheimer's disease.A novel study on amyloid β peptide 40, 42 and 40/42 ratio in Saudi autistics.Therapeutic potential of oxidant mechanisms in Alzheimer's disease.Amyloid-beta aggregation.Amyloidosis in Alzheimer's Disease: The Toxicity of Amyloid Beta (A β ), Mechanisms of Its Accumulation and Implications of Medicinal Plants for TherapyMetallo-complex activation of neuroprotective signalling pathways as a therapeutic treatment for Alzheimer's disease.Immunosenescence, inflammation and Alzheimer's disease.Effect of oxidative stress induced by intracranial iron overload on central pain after spinal cord injury.Capturing a reactive state of amyloid aggregates: NMR-based characterization of copper-bound Alzheimer disease amyloid β-fibrils in a redox cycle.Oxidative stress and cell membranes in the pathogenesis of Alzheimer's disease.Iron-chelating backbone coupled with monoamine oxidase inhibitory moiety as novel pluripotential therapeutic agents for Alzheimer's disease: a tribute to Moussa Youdim.Transition metal homeostasis: from yeast to human disease.The recent updates of therapeutic approaches against aβ for the treatment of Alzheimer's disease.Road to Alzheimer's disease: the pathomechanism underlying.Bioinformatics aggregation predictors in the study of protein conformational diseases of the human nervous system.Brain iron accumulation in aging and neurodegenerative disorders.Spontaneous and induced nontransgenic animal models of AD: modeling AD using combinatorial approach.Oxidative stress in Alzheimer's disease: Primary villain or physiological by-product?Nanoneurotoxicity to nanoneuroprotection using biological and computational approaches.Latest Study on the Relationship between Pathological Process of Inflammatory Injury and the Syndrome of Spleen Deficiency and Fluid Retention in Alzheimer's Disease.The Essential Role of Soluble Aβ Oligomers in Alzheimer's Disease.Pharmacological modulation of dietary lipid-induced cerebral capillary dysfunction: Considerations for reducing risk for Alzheimer's disease.Evidence For and Against a Pathogenic Role of Reduced γ-Secretase Activity in Familial Alzheimer's Disease.Amyloid beta plaque: a culprit for neurodegeneration.Glucocorticoid-Induced Leucine Zipper in Central Nervous System Health and Disease.Expression and Processing of Amyloid Precursor Protein in Vascular Endothelium.Effects of zinc on SN56 cholinergic neuroblastoma cells.Beta-amyloid expression, release and extracellular deposition in aged rat brain slices.
P2860
Q26822002-3E1CEEF2-E30A-4FE7-819C-59FB69E17999Q26864964-BCFF9A16-1352-4F14-8290-3C1C16A022EEQ26991654-DE47958B-DA07-4384-892D-A60BDCDD5E21Q27001743-B62F604A-94F3-41F7-87CD-DA769A0F3A08Q27008826-FCF15797-83B6-4C93-A4E5-62E052BBD1C7Q28478772-A9EE65FC-5E80-484F-A8AA-A57201CF5581Q28586383-0C1CC7FF-065C-4D59-ACFA-0D580A5DBA99Q33207345-A5EA68DE-04CC-4503-AA60-6A65CE1C84F7Q33706685-6F8DD9A3-2BD5-4F1D-A311-474382B383FFQ34460764-4DA959BC-73CE-409F-B345-15399CD388C6Q34572079-618EC880-B7C6-4CA4-84EB-FE5CAFA63447Q34616619-D43EE40C-1B29-4969-9C51-9C55BF9BE3D6Q35964717-AD6015D0-34AE-456F-8A10-2C36F56388A6Q36099067-78BEAB9A-8659-4337-8300-26E56AC26AEBQ36106911-9A4C9398-9AEA-4AB5-878E-9ECD492A2E06Q36788949-AD6FBD4E-36E1-4506-A606-917CA2BB446FQ36898656-A43C8B3A-5F38-42E4-82C3-F94CAD8EA0FCQ37373364-38DA783D-0CDC-499A-936A-B045F76F6DFAQ37581248-0F08AA68-269F-4F61-B265-A0B9C0CCAE83Q37633719-4F920F71-7EB6-4DBA-9F7D-26073CDE9BB1Q37683429-215295C9-9D87-47B2-A64A-E75F89CF3730Q37847817-15F6CF7F-CD33-48EE-BBB5-A94352BBE069Q37848245-C89DF68B-4830-43A1-9349-DF087FE0D3C7Q37863544-354DA685-B7B7-4B72-A71A-35F536037ACEQ37896029-676592C9-5C04-43ED-9EF1-284E5A5842BDQ37972068-F6DD1207-FCF5-4A23-BCB2-63A9882986A4Q38060618-E26050DF-9E4C-4913-8242-B83DBD777D09Q38067144-4EC8C298-3DC6-4704-B57A-B6C6D065CED5Q38107922-6765A5D9-D20E-4F4A-9E98-386602A35196Q38121221-4361B025-CBE4-4EF8-A956-74DA30B507CCQ38136249-A3FF945D-56DC-4C11-959B-814ABBA45A1BQ38209663-357F30B1-4745-457D-9B2B-B2AE80BA3DA1Q38400601-E2F857DE-EF10-449D-BBEE-6CED25769168Q38672178-8A087B73-5FD5-407C-A2D0-B932B5071238Q38802911-A112F4B9-449D-4488-993A-25E5F06BC941Q38818728-65F75B79-305C-44E3-8833-4923ECD332E2Q39021109-2A810846-5CB8-4BC6-B7BD-1509D3301D2AQ39032252-EC04B1C4-B0A9-454D-B7DC-96AD8908B834Q40100945-179F64F8-DA96-4681-BC6B-1C3BBBEEBAC2Q40181446-80D8140E-2CE4-4963-9646-95EF6C0F4FB1
P2860
Amyloid-β: a chameleon walking in two worlds: a review of the trophic and toxic properties of amyloid-β
description
article
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована у вересні 2003
@uk
name
Amyloid-β: a chameleon walking ...... toxic properties of amyloid-β
@en
Amyloid-β: a chameleon walking ...... toxic properties of amyloid-β
@nl
type
label
Amyloid-β: a chameleon walking ...... toxic properties of amyloid-β
@en
Amyloid-β: a chameleon walking ...... toxic properties of amyloid-β
@nl
prefLabel
Amyloid-β: a chameleon walking ...... toxic properties of amyloid-β
@en
Amyloid-β: a chameleon walking ...... toxic properties of amyloid-β
@nl
P2093
P1476
Amyloid-beta: a chameleon walk ...... xic properties of amyloid-beta
@en
P2093
Craig S Atwood
Hsien Chan
Mark A Smith
Mark E Obrenovich
Tianbing Liu
P356
10.1016/S0165-0173(03)00174-7
P577
2003-09-01T00:00:00Z